Clinical Trial Update: An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating immunotherapy in combination with chemotherapy for gastric cancer and gastroesophageal junction cancers; the trial has completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Junction Cancer
• Gastric Cancer

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Gastric Cancer, Cancer of the Stomach | Phase 2 | Status: COMPLETED | Results posted: 2022-05-09